RxDoctor Payments Data

Lee Carter, APRN

Family · Ashland, KYNPI 1801235528

Payments from drug & device makers

$1,499in general payments, 2019–2025

Across 92 payments — averaging $16.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$618
  • Pfizer$173
  • Abbott$112
  • GSK$111
  • Biohaven Pharmaceuticals, Inc.$75
  • Johnson & Johnson$72
  • plus $339 from 12 others

What the payments were for

  • Food & beverage$1,499100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,499 in reported general payments places this provider in the 70th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$32,071
Medicare patients
257
Services billed
677

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide39$45,732
OzempicSemaglutide38$45,119
JanuviaSitagliptin Phosphate38$37,535
EliquisApixaban29$31,587
TrulicityDulaglutide11$20,090
FarxigaDapagliflozin Propanediol18$18,189
LinzessLinaclotide20$16,601
Aimovig AutoinjectorErenumab-Aooe20$14,044
Breo ElliptaFluticasone/Vilanterol15$13,975
TradjentaLinagliptin17$9,253
Albuterol Sulfate HfaAlbuterol Sulfate199$8,125
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$7,755
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$6,794
RestasisCyclosporine12$6,689
Fluticasone-SalmeterolFluticasone Propion/Salmeterol45$5,212

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$49$65,82350 claims
Novo NordiskOzempic$18$45,11938 claims
MerckJanuvia$30$37,53538 claims
PfizerEliquis$173$31,58729 claims
AbbVieLinzess, Restasis$618$23,28932 claims
GSKBreo Ellipta$111$13,97515 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,374 family providers in Kentucky.

Other family in Ashland

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →